Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Heart Rhythm. 2011 Oct;8(10):1516-22. doi: 10.1016/j.hrthm.2011.06.021. Epub 2011 Jun 21.
In patients with ischemic heart disease, ventricular tachycardia (VT) is associated with increased mortality and morbidity. Catheter ablation is useful for reducing VT therapies but remains challenging, and recurrences are common.
The purpose of this study was to assess the prognosis and safety of repeat catheter ablation procedures for postinfarct VT and to determine clinical and procedural predictors of outcomes.
From a total of 280 patients undergoing catheter ablation of postinfarct VT at one center, 107 consecutive patients having a repeat procedure after one or more prior failed catheter ablation procedures (PFCA group) were compared to 173 patients who underwent a single catheter ablation (SCA group) in the same study period.
Of the PFCA group, 75 (70.1%) had one procedure and 32 (29.9%) had two or more prior ablations. Ventricular function and age were similar between groups. Periprocedural complications occurred in 11.2% of patients in the PFCA group and 8.7% of patients in the SCA group (P = .484). The 1-year VT recurrence rate was higher in the PFCA group compared to the SCA group (32.6% vs 16.6%, P = .001). On multivariable analysis, prior ablation (hazard ratio [HR] 1.84, P = .018), left ventricular ejection fraction (HR 1.04, P = .019), and mean number of induced VTs (HR 1.17, P = .043) were independent predictors of VT recurrence.
Failure of initial ablation does not preclude subsequent successful ablation for postinfarct VT. Whether healing of prior lesions, change in arrhythmic substrate, or changes in antiarrhythmic therapy are factors that influence recurrence warrants further study.
在缺血性心脏病患者中,室性心动过速(VT)与死亡率和发病率增加相关。导管消融术有助于减少 VT 治疗,但仍然具有挑战性,且复发较为常见。
本研究旨在评估梗死后 VT 患者重复导管消融术的预后和安全性,并确定临床和程序预测因素。
在一家中心接受梗死后 VT 导管消融术的 280 例患者中,将 107 例在一次或多次先前失败的导管消融术(PFCA 组)后接受重复手术的连续患者与同一研究期间接受单次导管消融术(SCA 组)的 173 例患者进行比较。
在 PFCA 组中,75 例(70.1%)患者仅进行了一次手术,32 例(29.9%)患者进行了两次或更多次先前消融。两组患者的心室功能和年龄相似。PFCA 组有 11.2%的患者发生围手术期并发症,SCA 组有 8.7%的患者发生围手术期并发症(P =.484)。与 SCA 组相比,PFCA 组 1 年 VT 复发率更高(32.6%比 16.6%,P =.001)。多变量分析显示,先前消融(危险比 [HR] 1.84,P =.018)、左心室射血分数(HR 1.04,P =.019)和诱发 VT 的平均数量(HR 1.17,P =.043)是 VT 复发的独立预测因素。
初始消融失败并不排除随后梗死后 VT 的成功消融。以前病变的愈合、心律失常基质的变化或抗心律失常治疗的变化是否是影响复发的因素,这值得进一步研究。